Influence of selective nitric oxide synthetase inhibitor for treatment of refractory haemorrhagic shock

Resuscitation

Volumn 61, Issue 2, 2004, Pages 221-229

  Shirhan, Md ^a   Moochhala, Shabbir M ^b   Kerwin, Siew Yang Low ^a   Ng, Kian Chye ^b   Lu, Jia ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DSO NATIONAL LABORATORIES   (Singapore)

Author keywords

Aminoguanidina; Aminoguanidine; Choque hemorr gico; Haemorrhagic shock; Nitric oxide; Oxido n trico; Rat; rata; Ratos; SOC hemorr gico

Indexed keywords

AMINOGUANIDINE; ANGIOTENSIN; ASPARTATE AMINOTRANSFERASE; CREATININE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DRUG RESPONSE; DRUG SPECIFICITY; HEMORRHAGIC SHOCK; HISTOLOGY; MALE; NONHUMAN; ORGAN; PLASMA; PRESSURE; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; BIOLOGICAL MARKERS; BLOOD PRESSURE DETERMINATION; CREATININE; GUANIDINES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; SHOCK, HEMORRHAGIC; SURVIVAL RATE;

EID: 2342511505     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2004.01.005     Document Type: Article

References (38)

1. Bond R.F., Johnson G. Vascular adrenergic interactions during hemorrhagic shock. Fed. Proc. Fed. Am. Soc. Exp. Biol. 44:1985;281-289
2. Bond R.F., Manley E.S. Jr., Green H.D. Cutaneous and skeletal muscle vascular responses to hemorrhage and irreversible shock. Am. J. Physiol. 212:1967;488-493
3. Chien S. Role of sympathetic nervous system in surviving acute hemorrhage. Am. J. Physiol. 206(1):1964;21-23
4. Darby T.D., Watt D.T. Acidosis and blood epinephrine levels in hemorrhagic hypotension. Am. J. Physiol. 206(6):1964;1281-1284
5. Mellander S., Lewis D.H. Effect of hemorrhagic shock on the reactivity of resistance and capacitance vessels and on capillary filtration transfer in cat skeletal muscle. Cir. Res. 13:1963;105-118
6. Manger W.M., Boliman J.L., Maher F.T., Berkson J. Plasma concentration of epinephrine/norepinephrine in hemorrhagic shock and anaphylactic shock. Am. J. Physiol. 190:1957;310-316
7. Harrison D.C., Chidscy C.A., Braunwaid E. Effect of hemorrhagic shock on release of epinephrine by tyramine. Am. J. Physiol. 206:1964;1262-1266
8. Scornik O.A., Paladini A.C. Angiotensin blood levels in hemorrhagic hypotension and other related conditions. Am. J. Physiol. 206(3):1964;553-556
9. Askari B., Ferreri N.R. Regulation or prostacyclin synthesis by angiotensin II and TNF-α in vascular smooth muscle. Prostaglandins Other Lipid Mediat. 63:2001;175-187
10. Buchner M., Ittner K.P., Hobbhahn J., Taeger K., Kurtz A. Downregulation of angiotensin II type 1 receptor during sepsis. Hypertension. 8:2001;177-182
11. Oudat A., Vergely C., Ecarnot-Laubriet A., Rochette L. Angiotensin II activates NADP oxidase in isolated rat hearts subjected to ischemia-reperfusion. Eur. J. Pharmacol. 462:2003;145-154
12. Chesley L.C., Wynn R.M., Silverman N.I. Renal effects of angiotensin II infusion in normotensive pregnant and nonpregnant women. Cir. Res. 13:1963;232-238
13. Rees D.D., Palmer R.M.J., Moneada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A. 86:1990;3375-3378
14. Ochoa J.B., Udekwu A.O., Billiar T.R. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 214:1991;621-626
15. Thiemermann C., Szabo C., Mitchell J.A., Vane J.R. Vascular reactivity to vasoconstrictor agents and hemodynamics decompensation in hemorrhagic shock is mediated by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 90:1993;267-271
16. Pieber D., Horina G., Sandner-Kiesling A., Pieber T.R., Heinemann A. Pressor and mesenteric arterial hyporesponsiveness to ANG II is an early event in hemorrhagic hypotension in anesthetized rats. Cardiovasc. Res. 44:1999;166-175
17. Gill D.J., Low B.C., Grigor M.R. Interleukin-1β and tumor necrosis factor-α stimulate the cat-2 gene of the L-arginine transporter in cultured vascular smooth muscle cells. J. Biol. Chem. 10:1996;11280-11283
18. Howard-Jones N.A. CIOMS ethical code for experimentation. WHO Chronicle. 39:1995;51-56
19. Iskit A.B., Sungur A., Gedikoglu G., Guc O. The effects of bosentan, aminoguanidine and L-canavanine on mesenteric blood flow, spleen and liver in endotoxemic mice. Eur. J. Pharmacol. 379:1999;73-80
20. Thiemermann C., Szabo C., Mitchell J.A., Vane J.R. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 90:1993a;267-271
21. Huang C.J., Wood C.E., Nasiroglu O., Slovin P.N., Fang X., Skimming J.W. Resuscitation of hemorrhagic shock attenuates intrapulmonary nitric oxide formation. Resuscitation. 55(2):2002;201-209
22. Ungureanu-Longrois D., Balligand J.L., Kelly R.A., Smith T.W. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J. Mol. Cell. Cardiol. 27:1995;155
23. Harbrecht B.G., Billiar T.R., Stadler J., et al. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit. Care Med. 20:1992;1568
24. Petros A., Lamb G., Leone A., Moncada S., Bennett D., Vallanc P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28:1994;34
25. Vallance P., Moncada S. Role of endogenous nitric oxide in septic shock. New Horiz. 1:1993;77
26. Grosjean S.A., Arstall M.A., Mitchell R.N., et al. Inducible nitric oxide synthase and tumor necrosis factor in animal models of myocardial necrosis induced by coronary artery ligation or isoproterenol injection. J. Card. Fail. 5:1999;236
27. Ellis G., Adatia I., Yazdanpanah M., Makela S.K. Nitrite and nitrate analyses: a clinical biochemistry perspective. Clin. Biochem. 31(4):1998;195-220
28. Teng C.H., Shabbir M.M. Influence of L-arginine, aminoguanidine, and L-NAME on the survival rate in a rat model of hemorrhagic shock. Shock. 11:1999;51-57
29. Hooper D.C., Scott G.S., Zborek A., et al. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J. 14(5):2000;691-698
30. Wu C.C., Chen S.J., Szabo C., Thiemermann C., Vane J.R. Aminoguanidine attenuates the delayed circulatory failure and improve survival in rodents models of endotoxic shock. Br. J. Pharmacol. 114:1995;1666-1672
31. Hock C.E., Kingsley Y., Yue G., Wong P.K. Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Am. J. Physiol. 272(41):1997;H843-H850
32. Arkovitz M.S., Wispe J.R., Garcia V.F., Szabo C. Selective of the inducible isoform of nitric synthase prevents pulmonary transvascular flux during acute endotoxemia. J. Pediatr. Surg. 31(8):1996;1009-1015
33. Hua T.C., Moochhala S.M. Role of nitric oxide in hemorrhagic shocked-induced bacterial translocation. J. Surg. Res. 93(2):2000;247-256
34. Sato S.S., Nakajima Y., Iwamoto T., Bito H., Miyabe M. S-nitroso-N-acetylpenicillamine (SNAP) during hemorrhagic shock improves mortality as a result of recovery from vascular hyporeactivity. Anesth. Analg. 90:2000;362-368
35. Corbett J.A., Tilton R.G., Chang K., et al. Aminoguanidine, a novel of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes. 41:1992;552-556
36. Griffith M.J.D., Messent M., MacAlister R.J., Evan T.W. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110:1993;963-968
37. Ng K.C., Moochhala S.M., Shirhan Md., Yap E.L., Kerwin S.Y.L., Jia Lu. Preservation of neurological functions by nitric oxide synthase inhibitors following hemorrhagic shock. Neuropharmacology. 44(2):2003;244-252
38. Symington P.A., Ma X.L., Lefer A.M. Protective actions of S-nitroso-N-acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock. Methods Find. Exp. Clin. Pharmacol. 14(10):1992;789-797